反応 #10466
ord-d8b72c473c3d4b2989a2714c082313d6
反応方程式
(2-{[(3-chloro-2-methylphenyl)sulfonyl]amino}-1,3-thiazol-5-yl)acetic acid
EDCI
triethylamine
morpholine
→
desired product
収率 10.0%
3-chloro-2-methyl-N-[5-(2-morpholin-4-yl-2-oxoethyl)-1,3-thiazol-2yl]benzenesulfonamide
収率 10.0%
反応物
試薬
反応条件
詳細条件
See reaction.notes.procedure_details.
後処理
- 1洗浄The reaction mixture was then washed with 1 M HCl (2×15 mL)
- 2その他the organic layer was collected
- 3乾燥The organic phase was dried (MgSO4)
- 4濃縮concentrated under reduced pressure
- 5その他Purification
実験手順
To a solution of (2-{[(3-chloro-2-methylphenyl)sulfonyl]amino}-1,3-thiazol-5-yl)acetic acid (Example 3) (0.09 g, 0.25 mmol) in CH2Cl2 (5.0 mL) and DMF (0.5 mL) were added EDCI (0.05 g, 0.27 mmol), DMAP (0.02 g, 0.12 mmol), triethylamine (0.1 mL, 0.75 mmol) and morpholine (0.03 mL, 0.30 mmol). The reaction mixture was stirred at room temperature overnight. The reaction mixture was then washed with 1 M HCl (2×15 mL) and the organic layer was collected. The organic phase was dried (MgSO4) and concentrated under reduced pressure. Purification using preparative HPLC afforded the desired product (0.01 g) in 10% yield.